Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lehtovirta

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
American Journal of Hypertension|November 5, 1997
Characterization of the prediabetic stateL Groop, C Forsblom, M Lehtovirta
Human Molecular Genetics|October 9, 2001
CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten diseaseK Luiro, O Kopra, M Lehtovirta, et al.
Blood Pressure|April 21, 2017
Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild HypertensionP Trenkwalder, K Dahl, M Lehtovirta, et al.
Scandinavian Journal of Medicine & Science in Sports|October 5, 2017
Development of a nutrition knowledge questionnaire for young endurance athletes and their coachesM Heikkilä, R Valve, M Lehtovirta, et al.
Blood Pressure|October 3, 1998
Antihypertensive treatment with candesartan cilexetil does not affect glucose homeostasis or serum lipid profile in patients with mild hypertension and type II diabetesP Trenkwalder, K Dahl, M Lehtovirta, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 13, 2001
Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR)A Vaag, M Lehtovirta, P Thye-Rönn, et al.
Neurobiology of Aging|June 27, 2000
How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studiesM Lehtovirta, M P Laakso, G B Frisoni, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 13, 2001
Heritability of leptin levels and the shared genetic effects on body mass index and leptin in adult Finnish twinsJ Kaprio, J Eriksson, M Lehtovirta, et al.
Human Molecular Genetics|May 20, 1999
Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)I Järvelä, M Lehtovirta, R Tikkanen, et al.
Journal of Internal Medicine|May 18, 2006
Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose toleranceJ G Eriksson, M Lehtovirta, B Ehrnström, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
American Journal of Hypertension|November 5, 1997
Characterization of the prediabetic stateL Groop, C Forsblom, M Lehtovirta
Human Molecular Genetics|October 9, 2001
CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten diseaseK Luiro, O Kopra, M Lehtovirta, et al.
Blood Pressure|April 21, 2017
Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild HypertensionP Trenkwalder, K Dahl, M Lehtovirta, et al.
Scandinavian Journal of Medicine & Science in Sports|October 5, 2017
Development of a nutrition knowledge questionnaire for young endurance athletes and their coachesM Heikkilä, R Valve, M Lehtovirta, et al.
Blood Pressure|October 3, 1998
Antihypertensive treatment with candesartan cilexetil does not affect glucose homeostasis or serum lipid profile in patients with mild hypertension and type II diabetesP Trenkwalder, K Dahl, M Lehtovirta, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 13, 2001
Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR)A Vaag, M Lehtovirta, P Thye-Rönn, et al.
Neurobiology of Aging|June 27, 2000
How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studiesM Lehtovirta, M P Laakso, G B Frisoni, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 13, 2001
Heritability of leptin levels and the shared genetic effects on body mass index and leptin in adult Finnish twinsJ Kaprio, J Eriksson, M Lehtovirta, et al.
Human Molecular Genetics|May 20, 1999
Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)I Järvelä, M Lehtovirta, R Tikkanen, et al.
Journal of Internal Medicine|May 18, 2006
Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose toleranceJ G Eriksson, M Lehtovirta, B Ehrnström, et al.
Pageof 7